Medicamentos para Programa Salud Mental Cesam - Readjudicada en Id 2026-25-R117
MEDICAMENTOS PARA PROGRAMA SALUD MENTAL CESAM
28 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2026-2641-SE17 | 21-12-2017 | Winpharm SpA | $92.820 |
| 2026-2638-SE17 | 21-12-2017 | Laboratorios Recalcine S.A. | $1.406.580 |
| 2026-1102-SE17 | 21-12-2017 | Novofarma Service S.A. | $473.382 |
| 2026-2640-SE17 | 21-12-2017 | Synthon Chile Limitada | $428.400 |
| 2026-2623-SE17 | 18-12-2017 | Laboratorio Chile S.A. | $248.115 |
| 2026-2624-SE17 | 18-12-2017 | Laboratorios Andromaco S.A. | $459.459 |
| 2026-2637-SE17 | 18-12-2017 | Laboratorio Chile S.A. | $969.981 |
| 2026-2626-SE17 | 18-12-2017 | Laboratorios Recalcine S.A. | $858.192 |
| 2026-1101-SE17 | 18-12-2017 | Bestpharma S.A. | $110.670 |
| 2026-1106-SE17 | 18-12-2017 | Laboratorio Biosano S.A. | $21.182 |
| 2026-2622-SE17 | 18-12-2017 | Indopharma S.A. | $366.175 |
| 2026-2628-SE17 | 18-12-2017 | Novartis Chile S.A. | $141.122 |
| 2026-2629-SE17 | 18-12-2017 | Winpharm SpA | $104.720 |
| 2026-2639-SE17 | 18-12-2017 | Novartis Chile S.A. | $141.122 |
| 2026-2340-SE17 | 02-11-2017 | Laboratorios Andromaco S.A. | $90.440 |
| 2026-2341-SE17 | 02-11-2017 | Laboratorios Andromaco S.A. | $123.593 |
| 2026-2117-SE17 | 02-10-2017 | Laboratorios Andromaco S.A. | $669.256 |
| 2026-2118-SE17 | 02-10-2017 | Laboratorios Recalcine S.A. | $525.504 |
| 2026-2116-SE17 | 02-10-2017 | Laboratorios Andromaco S.A. | $298.690 |
| 2026-2119-SE17 | 02-10-2017 | Novartis Chile S.A. | $282.244 |
| 2026-1653-SE17 | 27-07-2017 | Synthon Chile Limitada | $142.800 |
| 2026-1652-SE17 | 21-07-2017 | Novartis Chile S.A. | $71.614 |
| 2026-1651-SE17 | 21-07-2017 | Laboratorios Recalcine S.A. | $949.620 |
| 2026-1650-SE17 | 21-07-2017 | Laboratorios Andromaco S.A. | $174.930 |
| 2026-1649-SE17 | 21-07-2017 | Indopharma S.A. | $86.180 |
| 2026-1383-SE17 | 06-06-2017 | Drogueria Farmoquimica del Pacifico SpA | $46.410 |
| 2026-1218-SE17 | 26-05-2017 | Laboratorios Recalcine S.A. | $256.683 |
| 2026-1097-SE17 | 26-05-2017 | Novartis Chile S.A. | $561.680 |
| 2026-1098-SE17 | 26-05-2017 | Laboratorios Recalcine S.A. | $2.394.518 |
| 2026-1104-SE17 | 26-05-2017 | Synthon Chile Limitada | $428.400 |
| 2026-1109-SE17 | 26-05-2017 | Winpharm SpA | $195.160 |
| 2026-1214-SE17 | 26-05-2017 | Laboratorios Andromaco S.A. | $202.776 |
| 2026-1217-SE17 | 26-05-2017 | Laboratorios Andromaco S.A. | $104.601 |
| 2026-1219-SE17 | 26-05-2017 | Laboratorios Recalcine S.A. | $101.745 |
| 2026-1220-SE17 | 26-05-2017 | Novartis Chile S.A. | $307.520 |
| 2026-1225-SE17 | 26-05-2017 | Novartis Chile S.A. | $105.315 |
| 2026-1226-SE17 | 26-05-2017 | Synthon Chile Limitada | $57.120 |
| 2026-1213-SE17 | 25-05-2017 | Laboratorio Chile S.A. | $8.657 |
| 2026-1212-SE17 | 25-05-2017 | Laboratorio Chile S.A. | $19.189 |
| 2026-1211-SE17 | 25-05-2017 | Itf Farma Chile S.A. | $71.400 |
| 2026-1209-SE17 | 25-05-2017 | Indopharma S.A. | $83.645 |
| 2026-1207-SE17 | 25-05-2017 | Indopharma S.A. | $304.164 |
| 2026-1203-SE17 | 25-05-2017 | Drogueria Farmoquimica del Pacifico SpA | $28.560 |
| 2026-1111-SE17 | 25-05-2017 | Indopharma S.A. | $506.940 |
| 2026-1108-SE17 | 25-05-2017 | Glaxosmithkline Chile Farmaceutica Limitada | $595.000 |
| 2026-1107-SE17 | 25-05-2017 | Drogueria Farmoquimica del Pacifico SpA | $46.410 |
| 2026-1103-SE17 | 25-05-2017 | Abbott Laboratories de Chile Ltda. | $304.640 |
| 2026-1100-SE17 | 25-05-2017 | Itf Farma Chile S.A. | $71.400 |
| 2026-1099-SE17 | 25-05-2017 | Laboratorios Andromaco S.A. | $873.579 |
| 2026-1096-SE17 | 25-05-2017 | Laboratorio Chile S.A. | $304.640 |
Fuente original:ficha mercadopublico.cl